Oded Oron

Mr. Oded Oron


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
ILIva Lukić
Iva Lukić
DGDmitriy Getselter
Dmitriy Getselter
OZOren Ziv
Oren Ziv
OOOded Oron
Oded Oron
EREli Reuveni
Eli Reuveni
EEEvan Elliott
Evan Elliott
Accumulating evidence demonstrates that the gut microbiota affects brain function and behavior, including depressive behavior. Antidepressants are the main drugs used for treatment of depression. We hypothesized that antidepressant treatment could modify gut microbiota which can partially mediate their antidepressant effects. Mice were chronically treated with one of five antidepressants (fluoxetine, escitalopram, venlafaxine, duloxetine or desipramine), and gut microbiota was analyzed, using 16s rRNA gene sequencing. After characterization of differences in the microbiota, chosen bacterial species were supplemented to vehicle and antidepressant-treated mice, and depressive-like behavior was assessed to determine bacterial effects. RNA-seq analysis was performed to determine effects of bacterial treatment in the brain. Antidepressants reduced richness and increased beta diversity of gut bacteria, compared to controls. At the genus level, antidepressants reduced abundances of Ruminococcus, Adlercreutzia, and an unclassified Alphaproteobacteria. To examine implications of the dysregulated bacteria, we chose one of antidepressants (duloxetine) and investigated if its antidepressive effects can be attenuated by simultaneous treatment with Ruminococcus flavefaciens or Adlercreutzia equolifaciens. Supplementation with R. flavefaciens diminished duloxetine-induced decrease in depressive-like behavior, while A. equolifaciens had no such effect. R. flavefaciens treatment induced changes in cortical gene expression, up-regulating genes involved in mitochondrial oxidative phosphorylation, while down-regulating genes involved in neuronal plasticity. Our results demonstrate that various types of antidepressants alter gut microbiota composition, and further implicate a role for R. flavefaciens in alleviating depressive-like behavior. Moreover, R. flavefaciens affects gene networks in the brain, suggesting a mechanism for microbial regulation of antidepressant treatment efficiency.

2 September 2014 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SNS Nardone
S Nardone
DSD Sharan Sams
D Sharan Sams
ERE Reuveni
E Reuveni
DGD Getselter
D Getselter
OOOded Oron
Oded Oron
EEEvan Elliott
Evan Elliott
Autism spectrum disorders (ASD) are a group of neurodevelopmental conditions characterized by dysfunction in social interaction, communication and stereotypic behavior. Genetic and environmental factors have been implicated in the development of ASD, but the molecular mechanisms underlying their interaction are not clear. Epigenetic modifications have been suggested as molecular mechanism that can mediate the interaction between the environment and the genome to produce adaptive or maladaptive behaviors. Here, using the Illumina 450 K methylation array we have determined the existence of many dysregulated CpGs in two cortical regions, Brodmann area 10 (BA10) and Brodmann area 24 (BA24), of individuals who had ASD. In BA10 we found a very significant enrichment for genomic areas responsible for immune functions among the hypomethylated CpGs, whereas genes related to synaptic membrane were enriched among hypermethylated CpGs. By comparing our methylome data with previously published transcriptome data, and by performing real-time PCR on selected genes that were dysregulated in our study, we show that hypomethylated genes are often overexpressed, and that there is an inverse correlation between gene expression and DNA methylation within the individuals. Among these genes there were C1Q, C3, ITGB2 (C3R), TNF- α, IRF8 and SPI1, which have recently been implicated in synaptic pruning and microglial cell specification. Finally, we determined the epigenetic dysregulation of the gene HDAC4, and we confirm that the locus encompassing C11orf21/TSPAN32 has multiple hypomethylated CpGs in the autistic brain, as previously demonstrated. Our data suggest a possible role for epigenetic processes in the etiology of ASD.

Verified
Journal Article
Open access
PDF file
OOOded Oron
Oded Oron
EEEvan Elliott
Evan Elliott
In recent decades it has become clear that Autism Spectrum Disorder (ASD) possesses a diverse and heterogeneous genetic etiology. Aberrations in hundreds of genes have been associated with ASD so far, which include both rare and common variations. While one may expect that these genes converge on specific common molecular pathways, which drive the development of the core ASD characteristics, the task of elucidating these common molecular pathways has been proven to be challenging. Several studies have combined genetic analysis with bioinformatical techniques to uncover molecular mechanisms that are specifically targeted by autism-associated genetic aberrations. Recently, several analysis have suggested that particular signaling mechanisms, including the Wnt and Ca2+/Calmodulin-signaling pathways are often targeted by autism-associated mutations. In this review, we discuss several studies that determine specific molecular pathways affected by autism-associated mutations, and then discuss more in-depth into the biological roles of a few of these pathways, and how they may be involved in the development of ASD. Considering that these pathways may be targeted by specific pharmacological intervention, they may prove to be important therapeutic targets for the treatment of ASD.

17 October 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
OOOded Oron
Oded Oron
DGDmitriy Getselter
Dmitriy Getselter
SSShahar Shohat
Shahar Shohat
EREli Reuveni
Eli Reuveni
ILIva Lukic
Iva Lukic
EEEvan Elliott
Evan Elliott
Autism spectrum disorder (ASD) presents a wide, and often varied, behavioral phenotype. Improper assessment of risks has been reported among individuals diagnosed with ASD. Improper assessment of risks may lead to increased accidents and self-injury, also reported among individuals diagnosed with ASD. However, there is little knowledge of the molecular underpinnings of the impaired risk-assessment phenotype. In this study, we have identified impaired risk-assessment activity in multiple male ASD mouse models. By performing network-based analysis of striatal whole transcriptome data from each of these ASD models, we have identified a cluster of glutamate receptor-associated genes that correlate with the risk-assessment phenotype. Furthermore, pharmacological inhibition of striatal glutamatergic receptors was able to mimic the dysregulation in risk-assessment. Therefore, this study has identified a molecular mechanism that may underlie risk-assessment dysregulation in ASD.

20 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EREli Reuveni
Eli Reuveni
DGDmitry Getselter
Dmitry Getselter
OOOded Oron
Oded Oron
EEEvan Elliott
Evan Elliott
While both individual transcription factors and cis-acting sites have been studied in relation to psychiatric disorders, there is little knowledge of the relative contribution of trans-acting and cis-acting factors to gene transcription in the brain. Using an RNA-seq approach in mice bred from two evolutionary-distinct mice strains, we determined the contribution of cis and trans factors to gene expression in the prefrontal cortex and amygdala, two regions of the brain relevant to the stress response, and the contribution of cis and trans factors in the prefrontal cortex after Chronic Social Defeat (CSD) in mice. More genes were regulated by cis-regulatory factors in both brain regions, underlying the importance of cis-acting gene regulation in the brain. However, there was an increase in genes regulated by trans-regulatory mechanisms in the amygdala, compared to the prefrontal cortex. These genes were involved in synaptic functions, and were enriched for binding sites for transcription factors, including Egr1. CSD induced an increase in genes regulated by trans-regulatory mechanisms in the prefrontal cortex, and induced a pattern similar to the unstressed amygdala. Overall, we show brain site-specific patterns in cis and trans regulatory mechanisms, and show that these patterns can be modified by a psychological trigger.

12 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EBEva Berkes
Eva Berkes
OOOded Oron
Oded Oron
AWAdriana K. Wood
Adriana K. Wood
PMPhineas N. Monsul
Phineas N. Monsul
NMNicholas T. Monsul
Nicholas T. Monsul
Micro- and nanoplastics (MNPs) are now recognized as ubiquitous dietary and environmental contaminants, yet practical strategies to reduce gastrointestinal exposure remain limited. This study evaluated whether Qi601, a heat-inactivated Limosilactobacillus fermentum biofilm-derived postbiotic, could bind plastic particles and reduce intestinal epithelial plastic burden. Prior probiotic studies have demonstrated live bacterial adsorption of MNPs and mitigation of MNP-associated toxicity in vivo; here, we evaluate whether a nonviable postbiotic preparation can produce analogous MNP-binding and epithelial-protective effects. Qi601 durably bound polystyrene nanoplastics under in vitro simulated digestion conditions. In Caco-2 intestinal epithelial monolayers, Qi601 reduced surface-associated and intracellular nanoplastic burden in both protection and rescue models, indicating decreased epithelial particle interaction both before and after established nanoplastic exposure. Multimodal imaging, including confocal microscopy, atomic force microscopy, and scanning electron microscopy, confirmed close physical association between Qi601 and nanoplastics. Finally, a first-in-human proof-of-concept chewing-gum study showed Qi601 binding in the human mouth to heterogeneous gum-derived microplastic fragments released during mastication. Together, these findings support the concept of postbiotic intervention for gastrointestinal epithelial protection against ingested MNPs.